{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:15:08Z","timestamp":1794852908501,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.038","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T12:20:25Z","timestamp":1194351625000},"page":"8782-8793","source":"Crossref","is-referenced-by-count":55,"title":["Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B"],"prefix":"10.1016","volume":"25","author":[{"given":"Xiaoyan","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateesh","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Scroggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Surman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Portner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Slobod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2007.10.038_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ppul.10169","article-title":"Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit","volume":"34","author":"McCormick","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.vaccine.2007.10.038_bib2","series-title":"Fields Virology","first-page":"1443","article-title":"Respiratory Syncytial Virus","author":"Collins","year":"2001"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.038_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/infdis\/161.4.640","article-title":"Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children","volume":"161","author":"Anderson","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.038_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2007.10.038_bib5","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.038_bib6","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1128\/JVI.73.10.8485-8495.1999","article-title":"Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.038_bib7","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"Johnson","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.038_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/JCM.24.2.197-202.1986","article-title":"Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine","volume":"24","author":"Murphy","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.038_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"Srikiatkhachorn","year":"1997","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.038_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"Sparer","year":"1998","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.038_bib11","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"Tebbey","year":"1998","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.038_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.inf.0000243164.47048.4b","article-title":"The effect of an interventional program on adherence to the american academy of pediatrics guidelines for palivizumab prophylaxis","volume":"25","author":"Afghani","year":"2006","journal-title":"Pediatr Infect DIs J"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.038_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ppul.20507","article-title":"Beyond randomized controlled trials: a \u201creal life\u201d experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab","volume":"41","author":"Mitchell","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.038_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1442-200X.2006.02222.x","article-title":"Results of clinical surveillance during the Japanese first palivizumab season in 2002\u20132003","volume":"48","author":"Kusuda","year":"2006","journal-title":"Pediatr Int"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.038_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/JVI.74.3.1187-1199.2000","article-title":"Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine","volume":"74","author":"Buchholz","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.038_bib16","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1128\/JVI.75.10.4594-4603.2001","article-title":"Recombinant bovine\/human parainfluenza virus type 3 (B\/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3","volume":"75","author":"Schmidt","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.10.038_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0264-410X(94)00074-W","article-title":"Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization","volume":"13","author":"Crowe","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.038_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-1702(94)90059-0","article-title":"An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines","volume":"32","author":"Murphy","year":"1994","journal-title":"Virus Res"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.038_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.vaccine.2005.08.064","article-title":"Induction of balanced immunity in BALB\/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope","volume":"24","author":"Zeng","year":"2006","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.10.038_bib20","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2005.01.039","article-title":"Peptide-based candidate vaccine against respiratory syncytial virus","volume":"23","author":"Yusibov","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.038_bib21","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1128\/JVI.78.11.5773-5783.2004","article-title":"Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro","volume":"78","author":"Elliott","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.038_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0264-410X(03)00570-X","article-title":"The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B","volume":"22","author":"Power","year":"2003","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2007.10.038_bib23","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1128\/JVI.77.20.10819-10828.2003","article-title":"Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3\u2032 proximal genome positions of bovine\/human parainfluenza virus type 3 on virus replication and immunogenicity","volume":"77","author":"Tang","year":"2003","journal-title":"J Virol"},{"issue":"50","key":"10.1016\/j.vaccine.2007.10.038_bib24","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2005.07.046","article-title":"A review of vaccine research and development: human acute respiratory infections","volume":"23","author":"Girard","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.038_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0264-410X(97)00217-X","article-title":"Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one","volume":"15","author":"Hurwitz","year":"1997","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2007.10.038_bib26","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.vaccine.2004.01.053","article-title":"Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults","volume":"22","author":"Slobod","year":"2004","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2007.10.038_bib27","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.1128\/JVI.76.16.8244-8251.2002","article-title":"The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction","volume":"76","author":"Bousse","year":"2002","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.038_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2443.1996.d01-261.x","article-title":"Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense","volume":"1","author":"Kato","year":"1996","journal-title":"Genes Cells"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.038_bib29","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1128\/JVI.78.11.6043-6047.2004","article-title":"Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV","volume":"78","author":"Takimoto","year":"2004","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.038_bib30","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.63.7.2941-2950.1989","article-title":"Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function","volume":"63","author":"Beeler","year":"1989","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.038_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/vim.2005.18.255","article-title":"Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus","volume":"18","author":"Takimoto","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2007.10.038_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.1968289","article-title":"Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive cells","volume":"247","author":"Woodland","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.038_bib33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.153.5.1198","article-title":"Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition","volume":"153","author":"Kappler","year":"1981","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.038_bib34","doi-asserted-by":"crossref","first-page":"9747","DOI":"10.1128\/JVI.72.12.9747-9754.1998","article-title":"Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions","volume":"72","author":"Takimoto","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.038_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.038_bib36","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.10.038_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/viro.1995.1079","article-title":"Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments","volume":"207","author":"Sangster","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.10.038_bib38","series-title":"Immunobiology, the immune system in health and disease","author":"Janeway","year":"2005"},{"issue":"9","key":"10.1016\/j.vaccine.2007.10.038_bib39","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/JCM.00187-06","article-title":"Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India","volume":"44","author":"Parveen","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.038_bib40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/JVI.67.2.1090-1093.1993","article-title":"Frequent polymerase errors observed in a restricted area of clones derived from the attachment (G) protein gene of respiratory syncytial virus","volume":"67","author":"Cane","year":"1993","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.038_bib41","first-page":"97","article-title":"Sequence and phylogenetic analysis of SH, G, and F genes and proteins of Human respiratory syncytial virus isolates from Singapore","volume":"47","author":"Lim","year":"2003","journal-title":"Acta Virol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2007.10.038_bib42","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1099\/0022-1317-82-9-2117","article-title":"Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes","volume":"82","author":"Venter","year":"2001","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.038_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.inf.0000133165.85909.08","article-title":"Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection","volume":"23","author":"Saez-Llorens","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.038_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"151","author":"Simoes","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.038_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2006.03.012","article-title":"Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment","volume":"121","author":"Bousse","year":"2006","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T21:54:33Z","timestamp":1588024473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":45,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011917"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}